Clinical Trial Posts on Medivizor
Navigation Menu

Clinical Trial Posts on Medivizor

Looking for patients with relapsed or unresponsive multiple myeloma to test a new antibody drug

Posted by on Aug 14, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study is examining the effectiveness of antibody drug tiragolumab with or without standard treatment for relapsed or unresponsive multiple myeloma or non-Hodgkin lymphoma. The main outcome would be the side effects experienced by patients 1 year after treatment.  The details Both multiple myeloma (MM) and non-Hodkin lymphoma...

Read More

Looking for patients with relapsed or unresponsive non-Hodgkin lymphoma to test a new antibody drug

Posted by on Aug 14, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study is examining the effectiveness of antibody drug tiragolumab with or without standard treatment for relapsed or unresponsive multiple myeloma or non-Hodgkin lymphoma. The main outcome would be the side effects experienced by patients 1 year after treatment.  The details Both multiple myeloma (MM) and non-Hodkin lymphoma...

Read More

Looking for participants with advanced colorectal cancer to test a new immunotherapy

Posted by on Aug 14, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 1 trial is examining the effectiveness of personalized tumor antigens (PTA) in the treatment of different advanced tumors. The main outcomes to be measured will be side effects and disease control. This study is being conducted in Arizona, California, Louisiana and New Jersey, US. The details While the tumor cells are growing,...

Read More

Looking for participants with metastatic non-small cell lung cancer to test a new immunotherapy

Posted by on Aug 14, 2019 in Lung cancer | 0 comments

In a nutshell This phase 1 trial is examining the effectiveness of personalized tumor antigens (PTA) in the treatment of different advanced tumors. The main outcomes to be measured will be side effects and disease control. This study is being conducted in Arizona, California, Louisiana and New Jersey, US. The details While the tumor cells are growing,...

Read More

Looking for participants with metastatic melanoma to test a new immunotherapy

Posted by on Aug 14, 2019 in Melanoma | 0 comments

In a nutshell This phase 1 trial is examining the effectiveness of personalized tumor antigens (PTA) in the treatment of different advanced tumors. The main outcomes to be measured will be side effects and disease control. This study is being conducted in Arizona, California, Louisiana and New Jersey, US. The details While the tumor cells are growing,...

Read More

Looking for patients with type 2 diabetes and high cholesterol to test a cholesterol-reducing drug combination

Posted by on Aug 14, 2019 in Diabetes mellitus | 0 comments

In a nutshell This trial is examining how effective the drug bempedoic acid is when used with ezetimibe (Zetia) to reduce cholesterol in patients with type 2 diabetes (T2D). The main outcome will be the measurement of patient’s cholesterol as well as heart disease risk, diabetes severity and drug side effects. This study is recruiting in...

Read More

Looking for participants with benign prostatic hyperplasia and overactive bladder to test a new drug

Posted by on Aug 14, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell This phase 3 trial is examining the effectiveness of vibegron in the treatment of overactive bladder symptoms (OAB) in patients with prostatic hyperplasia (BPH; enlarged prostatic gland). The main outcome of this trial will be a change in urgency episodes. This trial is being conducted in the US and Canada. The details A benign (not...

Read More

Looking for participants with benign prostatic hyperplasia and overactive bladder to test a new drug

Posted by on Aug 14, 2019 in Overactive bladder | 0 comments

In a nutshell This phase 3 trial is examining the effectiveness of vibegron in the treatment of overactive bladder symptoms (OAB) in patients with prostatic hyperplasia (BPH; enlarged prostatic gland). The main outcome of this trial will be a change in urgency episodes. This trial is being conducted in the US and Canada. The details A benign (not...

Read More

Looking for patients with BRAF positive inoperable colorectal cancer to test a new treatment combination

Posted by on Aug 14, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 1/2 trial is examining the best dose and side effects of a combined treatment with encorafenib (Braftovi), cetuximab (Erbitux) and nivolumab (Opdivo). The main outcome to be measured will be the tumor response to the treatment. This trial is being conducted in Texas, US. The details Colorectal cancer is one of the leading...

Read More

Looking for patients with relapsed multiple myeloma to test a biological drug and immune cell vaccine

Posted by on Jul 31, 2019 in Multiple Myeloma | 0 comments

In a nutshell This trial is investigating the effectiveness and side effects of nivolumab (Opdivo) with a dendritic cell vaccine for patients with multiple myeloma (MM). The main outcome of this study would be to see the number of patients that develop an allergic reaction to the treatment. This study is recruiting in Boston, MA, United...

Read More